An overview of prognostic factors in small cell lung cancer

British Journal of Cancer

Volumn 61, Issue 4, 1990, Pages 597-604

  Rawson, N S B ^b   Peto, J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

AGE; ARTICLE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; SODIUM BLOOD LEVEL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; CARCINOMA, SMALL CELL; FEMALE; GREAT BRITAIN; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MULTICENTER STUDIES; NEOPLASM STAGING; PROGNOSIS; SODIUM; SUPPORT, NON-U.S. GOV'T;

EID: 0025240684     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1990.133     Document Type: Article

References (24)

1. ALLAN, S.G., GREGOR, A., CORNBLEET, M.A. & 4 others (1984). Phase II trial of vindesine and VP 16213־ in the palliation of poor prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother. Pharmacol., 13, 106
2. CERNY, T., BLAIR, V., ANDERSON, H., BRAMWELL, V. & THATCHER, N. (1987). Pre-treatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int. J. Cancer, 39, 146
3. COX, D.R. (1972). Regression models and life tables (with discussion). J. R. Stat. Soc. B, 34, 187
4. CULLEN, M., MORGAN, D., GREGORY, W. & 27 others (1986). Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother. Pharmacol., 17, 157
5. LEE, E.T. (1980). Statistical Methods for Survival Data Analysis. Lifetime Learning Publications: Belmont, California
6. KARNOFSKY, D A. & BURCHENAL, J.H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, MacLeod, C.M. (ed.) p. 191. Columbia University Press: New York
7. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY (1979). Radiotherapy alone or with chemotherapy in the treatment of small cell carcinoma of the lung. Br. J. Cancer, 40, 1
8. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY (1981). Radiotherapy alone or with chemotherapy in the treatment of small cell carcinoma of the lung: the results at 36 months. Br. J. Cancer, 44, 611
9. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY (1983). Cytotoxic chemotherapy before and after radiotherapy compared with radiotherapy followed by chemotherapy in the treatment of small cell carcinoma of the bronchus: the results up to 36 months. Br. J. Cancer, 48, 755
10. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY (1989a). Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small cell lung cancer. Respir. Med., 83, 51
11. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY (1989). Controlled trial of twelve versus six courses of chemotherapy in the treatment of small cell lung cancer. Br. J. Cancer, 59, 584
12. MORITTU, L., EARL, H.M., SOUHAMI, R.L. & 5 others (1989). Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br. J. Cancer, 59, 801
13. SMYTH, J.F., FOWLIE, S.M., GREGOR, A. & 4 others (1986). The impact of chemotherapy on small cell carcinoma of the bronchus. Q. J. Med., 61, 969
14. SOUHAMI, R.L., GEDDES, D.M., SPIRO, S.G. & 5 others (1984). Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br. Med J., 288, 1643
15. SOUHAMI, R.L., BRADBURY, I., GEDDES, DM., SPIRO, S.G., HARPER, P.G. & TOBIAS, J.S. (1985). Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res., 45, 2878
16. SOUHAMI, R.L. & LAW, K. (1990). The prognosis of small cell lung cancer. Br. J. Cancer (in the press)
17. SPIRO, S.G., SOUHAMI, R.L., GEDDES, D.M. & 6 others (1989). Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br. J. Cancer, 59, 578
18. THATCHER, N., BARBER, P.V., HUNTER, R.D. & 4 others (1982). Eleven week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for ‘limited’ stage small cell bronchogenic carcinoma: a study from the Manchester Lung Tumour Group. Lancet, 1, 1040
19. THATCHER, N., CERNY, T., STOUT, R. & 5 others (1987). Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer. Cancer, 60, 2382
20. THATCHER, N., JAMES, R.D., STEWARD, W.P. & 4 others (1985a). Three months treatment with cyclophosphamide VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer. Cancer, 56, 1332
21. THATCHER, N., STOUT, R., SMITH, D.B. & 4 others (1985). Three months treatment with chemotherapy and radiotherapy for small cell lung cancer. Br. J. Cancer, 52, 327
22. VINCENT, M.D., ASHLEY, S.E. & SMITH, I.E. (1987). Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur. J. Cancer Clin. Oncol., 23, 1589
23. WORLD HEALTH ORGANIZATION (1979). WHO Handbook for Reporting Results of Cancer Treatment (WHO Offset Publication No. 48). World Health Organization: Geneva
24. ZUBROD, C.G., SCHNEIDERMAN, M., FREI, E. Ill & 16 others (1960). Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and thriethylene thiophosphoramide. J. Chron. Dis., 11, 7